Published in Health Business Week, June 30th, 2006
The CRO will provide the capacity and resources to develop Ascentia's preclinical contract research through Ascentia Biomedical Technologies, Inc.
CROs provide independent product development services primarily for the pharmaceutical, biotechnology and medical device industries. Companies in these industries outsource product development services to CROs in order to manage the product development process more efficiently...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.